Europe PCR for Respiratory Infection Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Real-Time PCR (qPCR), Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase (RT-PCR), and Others), Product Type (Reagents & Kits, Instruments, and Others), Infection Type (Bacterial Infections, Viral Infections, and Fungal & Other Pathogens); End User (Hospitals, Physician Clinics, Clinical Laboratories, Academic & Research Institutions, Biotech & Pharma Companies, and Others), and Country

Market Introduction

Polymerase chain reaction (PCR) is used for accurate point-of-care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is generally preferred in inpatient and outpatient settings, which has helped improve the market's growth in recent years. The current outbreak of SARS CoV2 is boosting the growth of the market.

Get more information on this report :

Market Overview and Dynamics

The Europe PCR for respiratory infection diagnostics market is expected to reach US$ 2,432.46 million by 2028 from US$ 1,241.01 million in 2021. The market is anticipated to grow at a CAGR of 10.1% from 2021 to 2028. Increasing burden of chronic respiratory diseases (CRDs) and growing developments for PCR testing are expected to propel the growth of the market. However, availability of alternative assays is the major factor hindering the market growth.

Key Market Segments

In terms of type, the qPCR segment accounted for the highest share, and it is expected to dominate the largest market share in the coming future. The segment’s growth is majorly driven by its properties such as enormous dynamic range, remarkable sensitivity, ability to be very sequence-specific, little to no post-amplification processing, and increased sample throughput. Also, the regular developments for the PCR type are driving market.

Major Sources and Companies Listed

European Centre for Disease Prevention and Control, European Medicines Agency, European Respiratory Society, and Food and Drug Administration are among the major secondary sources for the Europe PCR for respiratory infection diagnostics market included in the report.

Reasons to Buy Report

To understand the Europe PCR for respiratory infection diagnostics market landscape and identify market segments that are most likely to guarantee a strong return
To stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe PCR for respiratory infection diagnostics market
To efficiently plan M&A and partnership deals in the Europe PCR for respiratory infection diagnostics market by identifying market segments with the most promising probable sales
To help in taking knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments that form the Europe PCR for respiratory infection diagnostics market
To obtain market revenue forecast for market by various segments from 2021 to 2028 in the region

Europe PCR for Respiratory Infection Diagnostics Market Segmentation

by Type

by Product Type

Reagents and Kits
Instruments
Others

by Infection Type

Bacterial Infections
- Bordetella
- Streptococcus Pneumoniae
- Staphylococcus Aureus
- Haemophilus Influenzae
- Moraxella Catarrhalis
- Mycoplasma Pneumoniae
- Chlamydophila Pneumoniae
- Legionella
- Others
Viral Infections
- Rhinoviruses
- Influenza Virus
- Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
- Respiratory Syncytial Virus (RSV)
- Adenovirus
- Enterovirus
- Parainfluenza
- Human Metapneumovirus (hMPV)
- Others
Fungal and Other Pathogens

Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe PCR for Respiratory Infection Diagnostics Market – By Type

1.3.2 Europe PCR for Respiratory Infection Diagnostics Market – By Product Type

1.3.3 Europe PCR for Respiratory Infection Diagnostics Market – By Infection Type

1.3.4 Europe PCR for Respiratory Infection Diagnostics Market – By End User

1.3.5 Europe PCR for Respiratory Infection Diagnostics Market – By Geography

2. PCR for Respiratory Infection Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. PCR for Respiratory Infection Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe– PEST Analysis

4.3 Expert Opinion

5. PCR for Respiratory Infection Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Burden of Chronic Respiratory Diseases (CRDs)

5.1.2 Growing Developments in PCR Testing

5.2 Market Restraints

5.2.1 Availability of Alternative Assays

5.3 Market Opportunities

5.3.1 Use of PCR Testing for Various Respiratory Infection Diagnostics

5.4 Future Trends

5.4.1 Developments in PCR Technology

5.5 Impact Analysis

6. PCR for Respiratory Infection Diagnostics Market – Regional Analysis

6.1 Europe PCR for Respiratory Infection Diagnostics Market Revenue Forecast And Analysis

6.2 Market Positioning

7. PCR for Respiratory Infection Diagnostics Market Analysis – By Type

7.1 Overview

7.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2020 and 2028)

7.3 Real Time PCR

7.3.1 Overview

7.3.2 Real Time PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Multiplex PCR

7.4.1 Overview

7.4.2 Multiplex PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Traditional PCR

7.5.1 Overview

7.5.2 Traditional PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Digital PCR

7.6.1 Overview

7.6.2 Digital PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Reverse Transcriptase (RT-PCR)

7.7.1 Overview

7.7.2 Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. PCR for Respiratory Infection Diagnostics Market Analysis – By Product Type

8.1 Overview

8.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Product Type (2020 and 2028)

8.3 Reagents and kits

8.3.1 Reagents and kits: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Instruments

8.4.1 Overview

8.4.2 Instruments: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. PCR for Respiratory Infection Diagnostics Market– By Infection Type

9.1 Overview

9.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Infection Type (2020 and 2028)

9.3 Bacterial Infection

9.3.1 Overview

9.3.2 Bacterial Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.3 Bordetella

9.3.3.1 Overview

9.3.3.2 Bordetella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.4 Streptococcus Pneumoniae

9.3.4.1 Overview

9.3.4.2 Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.5 Staphylococcus Aureus

9.3.5.1 Overview

9.3.5.2 Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.6 Haemophilus Influenzae

9.3.6.1 Overview

9.3.6.2 Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.7 Moraxella Catarrhalis

9.3.7.1 Overview

9.3.7.2 Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.8 Mycoplasma Pneumoniae

9.3.8.1 Overview

9.3.8.2 Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.9 Chlamydophila Pneumoniae

9.3.9.1 Overview

9.3.9.2 Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.10 Legionella

9.3.10.1 Overview

9.3.10.2 Legionella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.3.11 Others

9.3.11.1 Overview

9.3.11.2 Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4 Viral Infection

9.4.1 Overview

9.4.2 Viral Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.3 Rhinoviruses

9.4.3.1 Overview

9.4.3.2 Rhinoviruses: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.4 Influenza Virus

9.4.4.1 Overview

9.4.4.2 Influenza Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.5 Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus

9.4.5.1 Overview

9.4.5.2 Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.6 Respiratory Syncytial Virus (RSV)

9.4.6.1 Overview

9.4.6.2 Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.7 Adenovirus

9.4.7.1 Overview

9.4.7.2 Adenovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.8 Enterovirus

9.4.8.1 Overview

9.4.8.2 Enterovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.9 Parainfluenza

9.4.9.1 Overview

9.4.9.2 Parainfluenza: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.10 Human Metapneumovirus (hMPV)

9.4.10.1 Overview

9.4.10.2 Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.4.11 Others

9.4.11.1 Overview

9.4.11.2 Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

9.5 Fungal and Other Pathogens

9.5.1 Overview

9.5.2 Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10. PCR for Respiratory Infection Diagnostics Market– By End User

10.1 Overview

10.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by End User (2020 and 2028)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.4 Physician Clinics

10.4.1 Overview

10.4.2 Physician Clinics: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.5 Clinical Laboratories

10.5.1 Overview

10.5.2 Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.6 Academic and Research Institutions

10.6.1 Overview

10.6.2 Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.7 Biotech and Pharma Companies

10.7.1 Overview

10.7.2 Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

10.8 Others

10.8.1 Overview

10.8.2 Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

11. PCR for Respiratory Infection Diagnostics Market – Regional Analysis

11.1 Europe: PCR for Respiratory Infection Diagnostics Market

11.1.1 Overview

11.1.2 Europe: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.3 Europe: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.4 Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.5 Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.5.1 Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

11.1.5.2 Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

11.1.6 Europe: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7 Europe: PCR for Respiratory Infection Diagnostics Market, by Country, 2020 & 2028 (%)

11.1.8 Germany: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1 Germany: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.2 Germany: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.8.3 Germany: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.8.4 Germany: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.8.4.1 Germany: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections– Revenue and Forecast to 2028 (USD Million)

11.1.8.4.2 Germany: PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

11.1.8.5 Germany: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.9 UK: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.1 UK: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.2 UK: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.9.3 UK: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.9.4 UK: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.9.4.1 UK: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections– Revenue and Forecast to 2028 (USD Million)

11.1.9.4.2 UK: PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

11.1.9.5 UK: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.10 Norway: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.1 Norway: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.2 Norway: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.10.3 Norway: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.10.4 Norway: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.10.4.1 Norway: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections– Revenue and Forecast to 2028 (USD Million)

11.1.10.4.2 Norway: PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

11.1.10.5 Norway: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.11 Netherlands: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.11.1 Netherlands: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.11.2 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.11.3 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.11.4 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.11.4.1 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections– Revenue and Forecast to 2028 (USD Million)

11.1.11.4.2 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

11.1.11.5 Netherlands: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.12 Rest of Europe: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.12.1 Rest of Europe: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.12.2 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.1.12.3 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

11.1.12.4 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

11.1.12.4.1 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections– Revenue and Forecast to 2028 (USD Million)

11.1.12.4.2 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections– Revenue and Forecast to 2028 (USD Million)

11.1.12.5 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on PCR for Respiratory Infection Diagnostics Market

12.1 Europe: Impact Assessment of COVID-19 Pandemic

13. PCR For Respiratory Infection Diagnostics Market–Industry Landscape

13.1 Overview

13.2 Growth Strategies in the PCR For Respiratory Infection Diagnostics Market, 2020-2021

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Abbott

14.1.1 ey Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 F. HOFFMANN-LA ROCHE LTD.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Hologic, Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 BD

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 BIO-RAD LABORATORIES INC.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 bioMerieux SA

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 QIAGEN

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 THERMO FISHER SCIENTIFIC INC.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Seegene Inc

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 AusDiagnostics

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 Glossary of Terms

LIST OF TABLES

Table 1. Europe: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 2. Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3. Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 4. Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 5. Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 6. Europe: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. Germany: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 8. Germany: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 9. Germany: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 10. Germany: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 11. Germany: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 12. Germany: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. UK: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 14. UK: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 15. UK: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 16. UK: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 17. UK: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 18. UK: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 19. Norway: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 20. Norway: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 21. Norway: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 22. Norway: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 23. Norway: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 24. Norway: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 26. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 27. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 28. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 29. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 30. Netherlands: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 31. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 32. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 33. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type – Revenue and Forecast to 2028 (USD Million)

Table 34. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections – Revenue and Forecast to 2028 (USD Million)

Table 35. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections – Revenue and Forecast to 2028 (USD Million)

Table 36. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 37. Recent Inorganic Growth Strategies in the PCR For Respiratory Infection Diagnostics Market

Table 38. Recent Organic Growth Strategies in the PCR For Respiratory Infection Diagnostics Market

Table 39. Glossary of Terms, PCR for Respiratory Infection Diagnostics Market

LIST OF FIGURES

Figure 1. PCR for Respiratory Infection Diagnostics Market Segmentation

Figure 2. PCR for Respiratory Infection Diagnostics Market, By Region

Figure 3. Europe PCR for Respiratory Infection Diagnostics Market Overview

Figure 4. Real-Time PCR (qPCR) Segment Held Largest Share of Type Segment In PCR for Respiratory Infection Diagnostics Market

Figure 5. The UK Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Europe PCR for Respiratory Infection Diagnostics Market, Industry Landscape

Figure 7. Europe PEST Analysis

Figure 8. Expert Opinion

Figure 9. PCR for Respiratory Infection Diagnostics Market Impact Analysis of Drivers and Restraint

Figure 10. Europe PCR for Respiratory Infection Diagnostics Market – Revenue Forecast And Analysis – 2021- 2028

Figure 11. Europe PCR for Respiratory Infection Diagnostics Market – 2021- 2028

Figure 12. PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2020 and 2028)

Figure 13. Real Time PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Multiplex PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Traditional PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Digital PCR: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. PCR for Respiratory Infection Diagnostics Market Revenue Share, by Product Type (2020 and 2028)

Figure 20. Reagents and kits: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Instruments: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Others: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. PCR for Respiratory Infection Diagnostics Market Share, by Infection Type, 2020 and 2028 (%)

Figure 24. Bacterial Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 25. Bordetella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 26. Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 27. Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 28. Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 29. Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 30. Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 31. Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 32. Legionella: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 33. Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 34. Viral Infection: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 35. Rhinoviruses: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 36. Influenza Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 37. Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 38. Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 39. Adenovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 40. Enterovirus: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 41. Parainfluenza: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 42. Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 43. Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 44. Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 45. PCR for Respiratory Infection Diagnostics Market Share, by End User, 2020 and 2028 (%)

Figure 46. Hospitals: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 47. Physician Clinics: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 48. Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 49. Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 50. Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 51. Others: PCR for Respiratory Infection Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

Figure 52. Europe: PCR for Respiratory Infection Diagnostics Market, by Key Country – Revenue (2020) (USD Million)

Figure 53. Europe: PCR for Respiratory Infection Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 54. Europe: PCR for Respiratory Infection Diagnostics Market, by Country, 2020 & 2028 (%)

Figure 55. Germany: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 56. UK: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 57. Norway: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 58. Netherlands: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 59. Rest of Europe: PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 60. Impact of COVID-19 Pandemic in European Country Markets

Figure 61. Growth Strategies in the PCR For Respiratory Infection Diagnostics Market, 2020-2021

The List of Companies - Europe PCR for Respiratory Infection Diagnostics Market

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

Site License

$4000

Enterprise License

$5000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample